Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice.

× No keyword cloud information.

34 in total

1. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.

Authors: Kyung Min Chung; M Kathryn Liszewski; Grant Nybakken; Alan E Davis; R Reid Townsend; Daved H Fremont; John P Atkinson; Michael S Diamond
Journal: Proc Natl Acad Sci U S A Date: 2006-11-28 Impact factor: 11.205

2. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors: Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal: Hum Vaccin Immunother Date: 2012-08-16 Impact factor: 3.452

3. Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors: E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal: J Virol Date: 1985-06 Impact factor: 5.103

4. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.

Authors: Adrianus C M Boon; Jennifer deBeauchamp; Scott Krauss; Adam Rubrum; Ashley D Webb; Robert G Webster; Janet McElhaney; Richard J Webby
Journal: J Virol Date: 2010-05-19 Impact factor: 5.103

5. Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.

Authors: Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis
Journal: Viral Immunol Date: 2014-08-20 Impact factor: 2.257

6. Serum complement components in patients with trachoma.

Authors: D K Sen; G S Sarin; M Hiranandani; U K Baveja
Journal: Br J Ophthalmol Date: 1985-09 Impact factor: 4.638

7. Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.

Authors: Carolyn M Boudreau; Wen-Han Yu; Todd J Suscovich; H Keipp Talbot; Kathryn M Edwards; Galit Alter
Journal: J Clin Invest Date: 2020-02-03 Impact factor: 14.808

8. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.

Authors: C R Lambre; M Thibon; S Le Maho; G Di Bella
Journal: Immunology Date: 1983-06 Impact factor: 7.397

9. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

Authors: Adrianus C M Boon; Jennifer deBeauchamp; Anna Hollmann; Jennifer Luke; Malak Kotb; Sarah Rowe; David Finkelstein; Geoffrey Neale; Lu Lu; Robert W Williams; Richard J Webby
Journal: J Virol Date: 2009-08-12 Impact factor: 5.103

10. Activation of complement by cells infected with respiratory syncytial virus.

Authors: T F Smith; K McIntosh; M Fishaut; P M Henson
Journal: Infect Immun Date: 1981-07 Impact factor: 3.441